Market Cap 130.59M
Revenue (ttm) 32.31M
Net Income (ttm) -237.09M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -733.80%
Debt to Equity Ratio 0.00
Volume 2,111,000
Avg Vol 4,238,918
Day's Range N/A - N/A
Shares Out 83.71M
Stochastic %K 80%
Beta 2.16
Analysts Sell
Price Target $3.88

Latest News on EDIT

Editas Medicine Announces Chief Financial Officer Transition

Mar 20, 2025, 4:01 PM EDT - 4 weeks ago

Editas Medicine Announces Chief Financial Officer Transition


Editas Medicine to Participate in Upcoming Investor Conferences

Nov 6, 2024, 9:00 AM EST - 6 months ago

Editas Medicine to Participate in Upcoming Investor Conferences


Editas Medicine, Inc. (EDIT) Strategic Update Call Transcript

Oct 22, 2024, 11:45 AM EDT - 6 months ago

Editas Medicine, Inc. (EDIT) Strategic Update Call Transcript


Editas Medicine: A Risk/Reward Worth Considering

Sep 25, 2024, 11:46 AM EDT - 7 months ago

Editas Medicine: A Risk/Reward Worth Considering


Editas Medicine, Inc. (EDIT) Q2 2024 Earnings Call Transcript

Aug 7, 2024, 12:03 PM EDT - 9 months ago

Editas Medicine, Inc. (EDIT) Q2 2024 Earnings Call Transcript


Editas Medicine, Inc. (EDIT) Q1 2024 Earnings Call Transcript

May 8, 2024, 10:57 AM EDT - 1 year ago

Editas Medicine, Inc. (EDIT) Q1 2024 Earnings Call Transcript


Editas Medicine, Inc. (EDIT) Q4 2023 Earnings Call Transcript

Feb 28, 2024, 11:11 AM EST - 1 year ago

Editas Medicine, Inc. (EDIT) Q4 2023 Earnings Call Transcript